News | Endovascular Aortic Repair | December 05, 2022

Imagen Technologies Announces FDA Clearance of Aorta-CAD

New AI device expands Diagnostics as a Service platform capabilities. 

Designed to assist physicians detect findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia.

Designed to assist physicians detect findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia.  


December 5, 2022 —  Imagen Technologies, Inc. announced the U.S. Food and Drug Administration's 510(k) clearance of the computer-assisted detection (CADe) device Aorta-CAD. This new, FDA cleared device is designed to assist physicians at detecting findings on chest X-rays that are suggestive of Aortic Atherosclerosis and Aortic Ectasia. 

Aorta-CAD is a cloud-based, software-only medical device that uses deep learning to detect and highlight findings associated with Aortic Atherosclerosis and Aortic Ectasia. The device is part of Imagen's Diagnostics as a Service (DaaS) platform. It can assist any physician who reads chest X-rays, including radiologists and Primary Care Physicians (PCPs). 

This FDA clearance, Imagen's 4th, marks another major milestone for the company as it seeks to improve patient outcomes by making frontline imaging diagnostics suitable for PCP offices. By adding the Aorta-CAD device to its DaaS platform, Imagen expects to help Primary Care Physicians detect and treat these chronic diseases earlier and better. 

With assistance from Aorta-CAD, physicians are better equipped to diagnose and start treating Aortic Atherosclerosis and Aortic Ectasia earlier. Aorta-CAD presents an opportunity for practices to identify these previously undiagnosed chronic ailments, improve quality of life for their patients, and reduce total cost of care. 

Aorta-CAD identifies findings on the chest X-ray image and creates annotations that draw attention to those findings via an overlay. The overlay can be toggled off when not being used by the physician. It seamlessly integrates into existing X-ray reading workflows without the need for new PACS technology or costly re-training of physicians. 

"Imagen is on a mission to help Primary Care Physicians deliver faster, better diagnoses and care plans. By expanding our diagnostics as a service platform with Aorta-CAD, we expect to help PCPs significantly improve the quality of care and clinical outcomes for their patients with undiagnosed Aortic Atherosclerosis and Aortic Ectasia," says Alex Dresner, CEO at Imagen Technologies.  

Like other components of Imagen's platform, Aorta-CAD delivers significant results for patients, physicians, and the health care system. Per Aorta-CAD's clinical trial

62% relative reduction by physicians in misses for aortic calcification suggestive of Aortic Atherosclerosis 

35% relative reduction in misses for dilated aorta suggestive of Aortic Ectasia 

96% of physicians showed improvement when assisted by Imagen's device 

"Aorta-CAD assists the physician to have a consistent and repeatable process to look into the cardiac silhouette providing additional information to enhance the patient's treatment plans and care," said Scott Howell, Imagen's Chief Medical Officer. 

For more information: https://imagen.ai/ 


Related Content

News | Cardiac Imaging

July 17, 2025— Heartflow, Inc. recently announced new data for its AI-enabled Heartflow Plaque Analysis, including final ...

Home July 17, 2025
Home
News | Cardiac Imaging

July 15, 2025 – Cleerly has announced that EviCore, a leading radiology benefit manager providing coverage guidelines to ...

Home July 16, 2025
Home
News | Cardiac Imaging

July 11, 2025 — Heartflow, Inc. has announced that its Heartflow Plaque Analysis will be included in updated cardiac ...

Home July 15, 2025
Home
News | Cardiac Imaging

July 9, 2025 — Cleerly, a leader in advanced cardiovascular imaging, will be presenting new research at the Society of ...

Home July 15, 2025
Home
News | Cardiac Imaging

Cleerly, a leader in cardiovascular imaging, today announced the promotions of two key executives to expanded leadership ...

Home July 02, 2025
Home
News | Cardiac Imaging

June 25, 2025 — Royal Philips and Methodist Hospitals recently announced the healthcare provider’s strategic investment ...

Home June 25, 2025
Home
News | Cardiac Imaging

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Home June 12, 2025
Home
News | Cardiac Imaging

April 1, 2025 — UltraSight recently announced the presentation at the American College of Cardiology (ACC) Annual ...

Home April 15, 2025
Home
News | Cardiac Imaging

April 3, 2025 — Tower Health and Siemens Healthineers recently announced a 10-year agreement focused on equipment ...

Home April 04, 2025
Home
News | Cardiac Imaging

Pfizer has awarded $80,000 to Rutgers Robert Wood Johnson Medical School (RWJMS) to fund an Amyloidosis Fellowship at ...

Home December 19, 2024
Home
Subscribe Now